Search results
What's Going With Moderna Stock On Friday? - Moderna (NASDAQ:MRNA)
Benzinga· 7 days agoThe agency, citing administrative constraints, does not expect to complete its review of the Biologics License Application (BLA) for mRNA-1345, Moderna’s investigational respiratory ...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall By Investing.com
Investing.com· 7 days agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks...
FDA delays decision on Moderna's RSV shot until the end of May
FierceBiotech· 7 days agoModerna will have to consider that after receiving word that the FDA will not meet a May 12 decision...
Genetics Played a Role in Blood Clots Linked to COVID-19 Shots
Time Magazine· 1 day agoAdenovirus-based vaccines, like the J&J and AstraZeneca shots that were later pulled from the...
Do We Have Enough Bird Flu Vaccines for a Potential Pandemic?
Scientific American· 18 hours agoThe Centers for Disease Control and Prevention and many experts maintain that the public health risk...
Benjamin F. Edwards & Company Inc. Raises Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 6 days agoBenjamin F. Edwards & Company Inc. raised its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 17.2% during the 4th quarter, according to its most recent filing ...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? | The Motley Fool
The Motley Fool· 3 days agoThe market was responding to terrific news from Sanofi (NASDAQ: SNY), a global pharmaceutical giant...
Wealthspire Advisors LLC Has $301,000 Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 5 days agoWealthspire Advisors LLC trimmed its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 7.9% in the fourth quarter, according to its most recent disclosure with the Securities ...
FDA Delays Decision on Moderna RSV Shot by 3 Weeks
Barrons.com· 7 days agoThe agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 7 days agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...